Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creon versus placebo for pancreatic exocrine insufficiency after acute necrotizing pancreatitis
2013-005310-35Phase 4Active
- Sponsor
- Fundación para la Investigación en Enfermedades del Aparato Digestivo
- Start
- Jul 2014
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Insulin and Analogs → Hormones & Growth Factors → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in exocrine pancreatic insufficiency (EPI) comparing Creon with Placebo (2 arms). Primary endpoint: Change in fat digestion by 13C-MTG breath test. Started Jul 2014; status: active.
02
Drugs
pancreatin
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on 2013-005310-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005310-35.